問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taipei Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2023-05-09 - 2026-07-31
Condition/Disease
Test Drug
Participate Sites4Sites
Recruiting4Sites
2023-04-01 - 2025-12-31
Malignant Solid Tumor
Gen1042
Participate Sites7Sites
Recruiting7Sites
2022-02-01 - 2028-02-15
2021-11-01 - 2026-08-02
Participate Sites3Sites
Recruiting3Sites
2022-06-01 - 2022-08-19
Participate Sites5Sites
Terminated5Sites
2022-05-01 - 2023-02-23
Participate Sites2Sites
Recruiting2Sites
2023-11-01 - 2028-12-31
Participate Sites8Sites
Recruiting8Sites
2021-04-01 - 2029-09-01
Participate Sites9Sites
Terminated7Sites
2021-08-15 - 2024-12-31
2020-12-01 - 2023-12-31
Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements
Futibatinib（TAS-120）
Participate Sites6Sites
Recruiting6Sites
全部
